Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NPA's Dennin opens global consultancy

This article was originally published in The Tan Sheet

Executive Summary

Randy Dennin, of the Natural Products Association China, opens a consultancy to help small and mid-size dietary supplement and food firms expand products globally. Randy Dennin and Associates will use an international network of people to help firms expand globally by aiding with registration, formulation, contract manufacturing, marketing, advertising and distribution, Dennin says. He adds his international experience, including founding and chairing for nine years the International Alliance of Dietary/Food Supplement Associations, prepared him

You may also be interested in...

Patience Key Virtue For Penetrating Global Markets - Dennin

Patience and a focus on the long term are keys for firms pursuing approval in emerging markets, says industry expert Randy Dennin

EU Regulatory Round-Up, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty

Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.

Emerging Markets Help Fresenius Kabi Offset US Pressures

Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts